Cumulative seroprevalence of SARS-CoV-2 antibodies among blood donors in Burkina Faso, April 2022
The Journal of Infection in Developing Countries · 2025
DOI: 10.3855/jidc.18381 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Infection in Developing Countries, 2025. Verfasst von Salam Sawadogo und 23 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Haematology, University Joseph KI-ZERBO, Ouagadougou, Burkina Faso. Hauptthemen laut MEDLINE: Blood Donors, COVID-19, Antibodies, Viral, SARS-CoV-2. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
In Sub-Saharan Africa, the true extent of the COVID-19 pandemic is not known due to the low number of tests performed and the large proportion of asymptomatic cases in the populations. This was a seroprevalence study of SARS-CoV-2 antibodies in blood donors to assess the extent of virus circulation in Burkina Faso. Methodology: It was a cross-sectional study that included unpaid blood donors between March and April 2022. A rapid diagnostic test was used to screen SARS-CoV-2 antibodies in donors' plasma. Adjustment was made based on the performance of the test evaluated in a national quality control.
Results
A total of 3,084 blood donors were recruited, of whom 58.7% were male and 59.8% were from urban areas. The mean age was 22.9 ± 5.8 years, with donors aged 20 to 29 years accounting for 64.2%. The adjusted seroprevalence was 87.2%; 95% CI (86.4– 87.9). There was no difference in SARS-CoV-2 seropositivity between men and women, and between urban and rural areas. Donors aged 30-39 years had 0.5-fold lower odds of having SARS-CoV-2 antibodies than those under 20. Similarly, compared to Bobo-Dioulasso, blood donors from the Dédougou, Fada N'Gourma, and Koudougou centres had 0.5, 0.2, and 0.5 times lower odds of having SARS-CoV-2 antibodies, respectively.
Conclusions
The study indicates a high population exposure to SARS-CoV-2, in contrast with the official reports from the national surveillance system. It underscores the need to strengthen surveillance and public health interventions both in urban and rural areas.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Haematology, University Joseph KI-ZERBO, Ouagadougou, Burkina Faso.
- Health Sciences Research Institute , Ouagadougou, Burkina Faso.
- Regional blood transfusion centre of Gaoua, Burkina Faso.
- Regional blood transfusion centre of Koudougou, Burkina Faso.
- Regional blood transfusion centre of Tenkodogo, Burkina Faso.
- Regional blood transfusion centre of Ouahigouya, Burkina Faso.
Zitieren
APA
Sawadogo, S., Diallo, Y., Nebie, K., Meda, B. I., Djerma, C. Y., Ouedraogo, G. P., Kima, D., Sawadogo, S. M., Kafando, A., Coulibaly, S., Nana, B. C. A., Yonli, D. Y., Ouedraogo, M., Siritie, A. P., Zida, S., Dabire, C. S., Traore, R., Konate, K. A., Benao, A., …, & Ouedraogo, G. H. (2025). Cumulative seroprevalence of SARS-CoV-2 antibodies among blood donors in Burkina Faso, April 2022. The Journal of Infection in Developing Countries. https://doi.org/10.3855/jidc.18381
Vancouver
Sawadogo S, Diallo Y, Nebie K, Meda BI, Djerma CY, Ouedraogo GP, et al. Cumulative seroprevalence of SARS-CoV-2 antibodies among blood donors in Burkina Faso, April 2022. The Journal of Infection in Developing Countries. 2025. doi:10.3855/jidc.18381
BibTeX
@article{Sawadogo2025,
author = {Sawadogo, Salam and Diallo, Yacouba and Nebie, Koumpingnin and Meda, Bertrand Ivlabèhirè and Djerma, Corneille Ydriss and Ouedraogo, Georges Pengdwendé and Kima, Donatien and Sawadogo, Serge Mamadou and Kafando, Amadou and Coulibaly, Sinaré and Nana, Bachirou Cheickh Ashmed and Yonli, Dieudonné Yetema and Ouedraogo, Martin and Siritie, Anita Pierrette and Zida, Sylvie and Dabire, Charlemagne Sanhitouo and Traore, Rakiatou and Konate, Kadidiatou Aïna and Benao, Anita and Zalla, Seimbou and Sontie, Sonia and Deneys, Veronique and Kafando, Eléonore and Ouedraogo, Gautier Henri},
title = {Cumulative seroprevalence of SARS-CoV-2 antibodies among blood donors in Burkina Faso, April 2022},
journal = {The Journal of Infection in Developing Countries},
year = {2025},
doi = {10.3855/jidc.18381}
}
EUVIMED